Medicinal Cannabis
The Carlat Addiction Treatment Report, Volume 10, Number 6&7, August 2022
https://www.thecarlatreport.com/newsletter-issue/catr10n6-7/
Issue Links: Learning Objectives | Editorial Information
Topics: Cannabis | Legal issues | medicinal cannabis
Deepak Cyril D’Souza, MD
Professor of Psychiatry, Yale University School of Medicine. Psychiatrist, VA Connecticut Healthcare System, New Haven, CT.
Dr. D’Souza, expert for this educational activity, has disclosed that he owns stocks in Jazz Pharmaceuticals and Biohaven Pharmaceuticals. Dr. Capurso has reviewed the content of this interview and determined that there is no commercial bias as a result of these financial relationships.
Laws permitting the use of cannabis for medicinal purposes are being passed around the country, but what are we to make of this new and evolving legal patchwork? Dr. D’Souza describes the process and implications of state-specific legislation, and reviews the evidence, or lack thereof, for cannabis treatment of psychiatric disorders.
You can't view details of this content, please login or buy subscription here